Compare Intel Corp (INTC) vs Novavax Inc (NVAX) Price & Performance

Intel CorpTrade

Novavax IncTrade

Price performance (Past 24H)

Key statistics

Intel Corp vs Novavax Inc — how do they compare? Intel Corp trades at $99.79 (market cap $492.85B), while Novavax Inc trades at $7.97 (market cap $1.31B). The key difference: Intel Corp is far larger — about 376.2× Novavax Inc's market cap, and Intel Corp pays a 2.24% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

	INTC	NVAX
Market Cap	$492.85B	$1.31B
Volume	43,552,012	—
Sector	Technology	Health
52-Week High	$140.94	$11.19
52-Week Low	$21.81	$6.22
Enterprise Value	$513.66B	$889.30M
Dividend Yield	2.24%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INTC

Polen 5Perspectives Large Growth Portfolio outperforms Russell 1000 Growth with 26.63% return in Q2 2026Seeking Alpha · 13 hours agoBullish Intel stock upgraded to Buy as Q2 revenue jumps 25%, margins expand, and outlook beats expectations.Seeking Alpha · 1 day agoBullish Intel stock soars 370% in a year, fueled by Nvidia partnership and AI demand.Finbold · 1 day agoBullish View details →

NVAX

View details →

About Intel Corp

Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.